The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,030,499 in first-year total cost, median $613,700.
Most frequent study sections
- Special Emphasis Panel[ZDA1 SXC-G (01)]5
Most frequent institutions
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
- SEATTLE CHILDREN'S HOSPITAL1
- UNIVERSITY OF CALIFORNIA AT DAVIS1
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
- UNIVERSITY OF MINNESOTA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Behavior-based discovery of small-molecule modulators of neurochemical signaling pathways that underlie addiction1R01DA056358-01 | FANG-YEN, CHRISTOPHERRINGSTAD, NIELSSEYEDSAYAMDOST, MOHAMMAD R | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $646,068 | ZDA1 |
| 2022 | Regulation of Opioid Sensitivity and Tolerance by Ubiquitin Ligase Signaling1R01DA056370-01 | GRILL, BROCKZHENG, NING | SEATTLE CHILDREN'S HOSPITAL, WA | $629,577 | ZDA1 |
| 2022 | Spatiotemporal signaling and trafficking of the mu-opioid receptor1R01DA056354-01 | HUTTENHAIN, RUTH | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $613,700 | ZDA1 |
| 2022 | Identification of small molecules that regulate endogenous opioid signaling by inhibiting angiotensin converting enzyme1R01DA056331-01 | MORE, SWATI SROTHWELL, PATRICK | UNIVERSITY OF MINNESOTA, MN | $589,000 | ZDA1 |
| 2022 | High-throughput Identification of Non-hallucinogenic Psychoplastogens for Treating Addiction1R01DA056365-01 | OLSON, DAVID E | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $552,154 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.